Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

California

Phase 2 colorectal cancer trials in California

26 Phase 2 colorectal cancer studies are recruiting participants at sites in 19 cities across California as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse California by city

Cities with the most studies recruiting right now.

Every California city with a recruiting study

Los Angeles (12), Duarte (8), Orange (5), Irvine (3), Santa Monica (3), Beverly Hills (2), Santa Rosa (2), Corona (1), Encino (1), Fullerton (1), Huntington Beach (1), Koreatown (1), La Jolla (1), Long Beach (1), Newport Beach (1), San Francisco (1), South Pasadena (1), Upland (1), West Covina (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in California

Basic details from each study's public record (the 12 most recently updated of 26). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Los Angeles
    Registry record
    NCT07659795 · updated
  2. Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Solstice Oncology, Inc.
    Recruiting in
    Los Angeles
    Registry record
    NCT07808151 · updated
  3. Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Los Angeles
    Registry record
    NCT04557449 · updated
  4. FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Oncolytics Biotech
    Recruiting in
    Beverly Hills · Encino · Koreatown · and 2 more U.S. locations
    Registry record
    NCT07446322 · updated
  5. A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Bayer
    Recruiting in
    Duarte
    Registry record
    NCT06760819 · updated
  6. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Recruiting in
    Beverly Hills · Irvine · Los Angeles · and 1 more U.S. location
    Registry record
    NCT05673148 · updated
  7. A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Duarte · Santa Monica
    Registry record
    NCT06820463 · updated
  8. Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Buzzard Pharmaceuticals
    Recruiting in
    Los Angeles · Newport Beach
    Registry record
    NCT06634875 · updated
  9. Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Delcath Systems Inc.
    Recruiting in
    Duarte · Santa Monica
    Registry record
    NCT06607458 · updated
  10. Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Recruiting in
    Corona · Duarte · Huntington Beach · and 4 more U.S. locations
    Registry record
    NCT07595874 · updated
  11. A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Fullerton · Los Angeles
    Registry record
    NCT07023289 · updated
  12. Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

    • Phase 2
    • Ages 18 to 130
    • All sexes
    Sponsor
    AstraZeneca
    Recruiting in
    Los Angeles · Santa Rosa
    Registry record
    NCT05489211 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in California on ClinicalTrials.gov.

Ask about studies in California

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call